These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 15380464)

  • 21. Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus Wiktor stent implantation: results from the Mayo-Japan Investigation for Chronic Total Occlusion (MAJIC) trial.
    Tamai H; Berger PB; Tsuchikane E; Suzuki T; Nishikawa H; Aizawa T; Fujii K; Nozaki Y; Kyo E; Kobayashi T; Reiber J; Van Weert AW;
    Am Heart J; 2004 Mar; 147(3):E9. PubMed ID: 14999211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention.
    Monraats PS; Fang Y; Pons D; Pires NM; Pols HA; Zwinderman AH; de Maat MP; Doevendans PA; DeWinter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Uitterlinden AG; Jukema JW
    Expert Opin Ther Targets; 2010 Mar; 14(3):243-51. PubMed ID: 20095921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophanyl-tRNA synthetase gene polymorphisms and risk of incident myocardial infarction.
    Zee RY; Hegener HH; Chasman DI; Ridker PM
    Atherosclerosis; 2005 Jul; 181(1):137-41. PubMed ID: 15939065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haplotypes of the angiotensin-converting enzyme (ACE) gene are associated with coronary artery disease but not with restenosis after coronary stenting.
    Martínez-Ríos MA; Alvarez-León E; Totomoch A; Angeles J; Peña-Duque MA; Delgadillo-Rodríguez H; Martínez-Rodríguez N; Ramírez-Fuentes S; Fragoso JM; Vargas-Alarcón G
    Exp Mol Pathol; 2014 Aug; 97(1):166-70. PubMed ID: 24995885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism in the C-reactive protein (CRP) gene affects CRP levels in plasma and one early marker of atherosclerosis in men: The Health 2000 Survey.
    Kettunen T; Eklund C; Kähönen M; Jula A; Päivä H; Lyytikäinen LP; Hurme M; Lehtimäki T
    Scand J Clin Lab Invest; 2011 Sep; 71(5):353-61. PubMed ID: 21413847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of polymorphism within the C-reactive protein gene and plasma CRP levels.
    Suk HJ; Ridker PM; Cook NR; Zee RY
    Atherosclerosis; 2005 Jan; 178(1):139-45. PubMed ID: 15585211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention.
    Monraats PS; de Vries F; de Jong LW; Pons D; Sewgobind VD; Zwinderman AH; de Maat MP; 't Hart LM; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; van der Laarse A; van der Wall EE; Wouter Jukema J
    Pharmacogenet Genomics; 2006 Oct; 16(10):747-54. PubMed ID: 17001294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach.
    Hegener HH; Diehl KA; Kurth T; Gaziano JM; Ridker PM; Zee RY
    J Thromb Haemost; 2006 Aug; 4(8):1718-22. PubMed ID: 16879213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting.
    Tiroch K; von Beckerath N; Koch W; Lengdobler J; Joost A; Schömig A; Kastrati A
    Atherosclerosis; 2005 Sep; 182(1):145-51. PubMed ID: 16115485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
    Pons D; Monraats PS; de Maat MP; Pires NM; Quax PH; van Vlijmen BJ; Rosendaal FR; Zwinderman AH; Doevendans PA; Waltenberger J; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
    Thromb Haemost; 2007 Dec; 98(6):1323-8. PubMed ID: 18064331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Different effects of inflammation and lipid levels on coronary lesions after PCI].
    Xu HY; Qiao SB; Li JJ; Yang YJ; Zhang JF; Xu B; Xie GQ; Dong QT
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2249-52. PubMed ID: 20095335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1059G/C polymorphism within the exon 2 of the C-reactive protein gene: relationship to C-reactive protein levels and prognosis in unstable angina.
    Rizzello V; Liuzzo G; Giannuario GD; Trabetti E; Brugaletta S; Santamaria M; Piro M; Pignatti PF; Maseri A; Biasucci LM; Crea F
    Coron Artery Dis; 2007 Nov; 18(7):533-8. PubMed ID: 17925606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
    Hoppmann P; Koch W; Schömig A; Kastrati A
    Eur Heart J; 2004 Feb; 25(4):335-41. PubMed ID: 14984923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis?
    Verschuren JJ; Sampietro ML; Pons D; Trompet S; Ewing MM; Quax PH; de Knijff P; Zwinderman AH; de Winter RJ; Tio RA; de Maat MP; Doevendans PA; Jukema JW
    Dis Markers; 2010; 29(5):265-73. PubMed ID: 21206012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents?
    Jung JH; Min PK; Kim JY; Park S; Choi EY; Ko YG; Choi D; Jang Y; Shim WH; Cho SY
    Cardiology; 2005; 104(2):72-5. PubMed ID: 16020923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periprocedural soluble P- and E-selectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting.
    Kozinski M; Kubica J; Sukiennik A; Zbikowska-Gotz M; Krzewina-Kowalska A; Radomski M; Rychter M; Bialoszynski T; Jablonski M; Demidowicz K; Grzesk G; Bogdan M; Chojnicki M; Grabczewska S; Dziedziczko A
    Int J Mol Med; 2007 Jan; 19(1):187-95. PubMed ID: 17143564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study.
    Grammer TB; März W; Renner W; Böhm BO; Hoffmann MM
    Eur Heart J; 2009 Jan; 30(2):170-82. PubMed ID: 18499652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-Reactive Protein Level and the Genetic Variant rs1130864 in the CRP Gene as Prognostic Factors for 10-Year Cardiovascular Outcome.
    Schulz S; Rehm S; Schlitt A; Lierath M; Lüdike H; Hofmann B; Bitter K; Reichert S
    Cells; 2023 Jul; 12(13):. PubMed ID: 37443809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Relationship between
    Osadnik T; Lekston A; Bujak K; Strzelczyk JK; Poloński L; Gąsior M
    Dis Markers; 2017; 2017():8165219. PubMed ID: 28811677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.